Biographical Sketch
Patrick L. Whitlow, MD, is Associate Director for Device Trials of C5Research and is Director of Interventional Cardiology in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine.
Dr. Whitlow’s specialty interests include cardiac catheterization, peripheral vascular and coronary angiography, coronary and peripheral vascular stenting, new interventional devices, percutaneous mitral valve repair and aortic valve replacement.
Dr. Whitlow’s research interests are focused on new cardiovascular device trials. He has been the national Principal Investigator in many trials and is experienced in presenting new device applications to the FDA. Current research includes studies with drug-eluting stents, carotid revascularization, chronic total occlusions, percutaneous aortic valve replacement, percutaneous mitral valve repair, renal stenting and percutaneous lower-extremity revascularization.
He has authored or coauthored over 30 book chapters and 170 articles in leading medical journals.
After receiving his medical degree from Duke University School of Medicine, Dr. Whitlow completed residency and internship training in internal medicine at Dallas County Parkland Hospital and a fellowship in cardiovascular medicine at the University of Alabama Hospital, Birmingham. He was Catheterization Laboratory Director at University of Alabama at Birmingham before joining Cleveland Clinic in 1986.
Specialty Interests
cardiac catheterization and angiography, coronary angioplasty, new coronary interventional devices, thrombolytic therapy
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 8/5/2008, Dr.
Whitlow has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Equity. Dr. Whitlow owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:
ICON
Medlogics
Medtronic, Inc.
Fiduciary Role. Dr. Whitlow serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:
Medlogics, Inc.
